NCT06747208Not yet recruiting
Dysphagia in Head and Neck Cancer With Radiation
The Impact of Swallowing and Nutrition in Head and Neck Cancer Patients Undergoing Chemo or Chemo-radiotherapy.
Source: ClinicalTrials.gov · Last updated 24 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study focuses on swallowing dysfunction, a common issue affecting 60-75% of head and neck cancer patients due to tumor damage, treatment complications, and chemoradiotherapy side effects, which can lead to malnutrition and reduced quality of life. With limited research on the effects of radiation doses on swallowing muscles and nutrition, this study aims to evaluate these impacts in non-surgical patients undergoing radiotherapy, conducting assessments before treatment, three months after, and within one year post-treatment.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 15 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT06747208
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Jan 2025 to the primary completion date, 31 Dec 2030
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients scheduled to undergo surgical treatment;
Other illness
- Patients with neuromuscular diseases, such as stroke or Parkinson's disease;
- Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;
- Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;
Other
- Patients who do not consent to undergo high-resolution impedance manometry.
Who the study is looking for
- Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;
- Aged between 18 and 80 years;
- Able to perform self-care independently (ECOG ≤ 2);
- All patients provide written informed consent.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.